BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis

VEGF inhibitors are one of the most successful antiangiogenic drugs in the treatment of many solid tumors. Nevertheless, pancreatic adenocarcinoma (PAAD) cells can reinstate tumor angiogenesis via activation of VEGF-independent pathways, thereby conferring resistance to VEGF inhibitors. Bioinformati...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Chongbiao, Li, Hui, Xu, Yang, Xu, Chao, Sun, Huizhi, Li, Zengxun, Ge, Yi, Wang, Hongwei, Zhao, Tiansuo, Gao, Song, Wang, Xiuchao, Yang, Shengyu, Sun, Peiqing, Liu, Zhe, Liu, Jing, Chang, Antao, Hao, Jihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344882/
https://www.ncbi.nlm.nih.gov/pubmed/37443111
http://dx.doi.org/10.1038/s41392-023-01478-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344882/
https://www.ncbi.nlm.nih.gov/pubmed/37443111
http://dx.doi.org/10.1038/s41392-023-01478-5

Ejemplares similares